Educational pharmaceutical intervention in leprosy patients who have completed treatment

Authors

DOI:

https://doi.org/10.60103/phc.v26.e834

Keywords:

leprosy; Pharmaceutical Care; health education

Abstract

Introduction: In his role as health educator, the pharmacist carries out specific interventions in chronic diseases such as the Educational Pharmaceutical Intervention (EPI) that can be applied in the Family Health Unit. (FHU)
Objective: To evaluate (EPI) in patients with leprosy who completed pharmacological treatment between 2011 and 2017 in Family Health Units (FHU) of five districts of the central department.
Method: It was carried out a quasi-experimental study in which 34 patients who completed pharmacological treatment against leprosy participated. Three home interviews were conducted with each patient. A self-made questionnaire was used to measure knowledge about the disease, treatment, transmission and quality of life through the SF-36 questionnaire before and after EPI.
Results: In the third interview, the patients improved their knowledge; higher percentages of correct answers were obtained in items such as leprosy reactions 100%, causes of the reactions 82.4%, frequency of medical control after treatment 61.8%, duration of follow-up 97%, manifestation of signs of leprosy in contacts up to 10 years after infection 97.1% and evaluation of contacts by health personnel 97.1%. The score improved in the general health item.
Conclusions: The results showed that patients who completed leprosy treatment and underwent intervention improved their knowledge in certain aspects. This evidences the usefulness of EPI as a health education strategy and could be implemented in Family Health Units.

Downloads

Download data is not yet available.

References

Organización Panamericana de la Salud. Plan de Acción para acelerar el logro de la eliminación de lepra en Latinoamerica y el Caribe; 2011 [Internet]. 2011 [Citado 20 mar 2022]. Disponible en: https://www.paho.org/es/documentos/plan-accion-para-acelerar-logro-eliminacion-lepra-america-latina-caribe-20112. Ebenezer GJ, Scollard DM.

Ebenezer GJ, Scollard DM. Treatment and Evaluation Advances in Leprosy Neuropathy. Neurotherapeutics. 2021; 18(4):2337-2350. [citado 30 jun 2023];18(4):2337-2350. doi: 10.1007/s13311-021-01153-z.

Costa M, Hiromi L, Carvalho L, Caldas S, Aguiar L, Santos M et al. Impact of educational intervention on leprosy on the level of knowledge of community health workers in Belém do Pará. Braz J.Hea. Rev. 2020; 3(4):8821-8837. DOI:10.34119/bjhrv3n4-127

World Health Organization, Regional Office for South-East Asia.Global Leprosy Strategy 2016-2020 [Internet]. 2016. [Citado 20 dic 2018]. Disponible en: https://www.paho.org/en/documents/global-leprosy-strategy-2016-2020-accelerating-towards-leprosy-free-world

Figueiredo N, Moura F, Martínez-Riera J, Nolasco A, Carlos F, Lana F. Orientación de la atención primaria en las acciones contra la lepra: factores relacionados con los profesionales. Gac Sanit. 2020; 34(2):120-126. https://dx.doi.org/10.1016/j.gaceta.2019.02.011

Organización Mundial de la Salud /Organización Panamericana de la Salud. Servicios Farmacéuticos basados en la Atención Primaria en Salud. Agencia Española de Cooperación Internacional para el Desarrollo (AECID). [Internet]. 2013. [Citado 25 mar 2019]. Disponible en: http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&gid=21582&Itemid=270

Cassyano J, Fleith M, Soler O. Servicios farmacéuticos integrados al proceso de cuidado en salud: gestión clínica del medicamento. Rev Pan-Amaz Saude [Internet]. 2011;2(3):41-49. doi: 10.5123/S2176-62232011000300006

Salazar-Ospina A, Carrascal V, Benjumea D, Amariles P. Clinical pharmacy, pharmaceutical care: Concepts, philosophy, professional practice and its application to the Colombian context. Vitae. 2012;19(1):109–129. Disponible en: https://www.redalyc.org/pdf/1698/169824077011.pdf

Lourdhurajan R, Pulimood SA, Eapen EP, et al. Health care utilisation in Indian leprosy patients in the era of elimination. Lepr Rev. 2010;81(4):299–305. Disponible en: https://pubmed.ncbi.nlm.nih.gov/21313975/

White C, Franco-Paredes C. Leprosy in the 21st century. Clin Microbiol Rev. 2015; 28(1):80-94. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284303/

Maidana G, Lugo G, Vera Z, Pérez S, Mastroianni P. Evaluación de un programa de Atención Farmacéutica en pacientes con diabetes mellitus tipo 2. Pharm Care Esp. 2016;18(1):3–15. Disponible en: https://www.pharmcareesp.com/index.php/PharmaCARE/article/view/259

Lugo De Ortellado G, De Bittner MR, Chávez G. H, Pérez S. Implementación de un programa de atención farmacéutica en farmacias comunitarias para la detección de la hipertensión arterial y su seguimiento farmacoterapéutico. Lat. Am. J. Pharm. 2007; 26(4):590–5. Disponible en:http://sedici.unlp.edu.ar/handle/10915/7521

Ministerio de Salud de Costa Rica. Caja Costarricense del Seguro Social Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud Universidad de Costa Rica. Normas para la Atención Integral y Control de la Enfermedad de Hansen en Costa Rica [Internet]. San José Costa Rica; 2012 [citado 30 nov 2019]. Disponible en: https: //www.binasss.sa.cr/protocolos/hansen.pdf

Trujillo G, Román J, Lombard H, Remior F , Arredondo N, Martinez P, et al. Adaptación del cuestionario SF-36 para medir calidad de vida relacionada con la salud en trabajadores cubanos. Revista Cubana de Salud y Trabajo. 2014;15(1):62–70. Disponible en: https://www.medigraphic.com/pdfs/revcubsaltra/cst-2014/cst141j.pdf

Kessler M, Thumé E, et al. Health education and promotion actions among teams of the National Primary Care Access and Quality Improvement Program, Rio Grande do Sul state, Brazil. Epidemiol Serv Saude. 2018;27(2):e2017389. doi: 10.5123/S1679-49742018000200019.

Lusli M, Peters R, Bunders J, Irwanto I, Zweekhorst M. Development of a rights based counselling practice and module to reduce leprosy-related stigma and empower people affected by leprosy in Cirebon District, Indonesia. Lepr Rev. 2017; 88(3):318–33. Disponible en: https://www.researchgate.net/publication/323737093_Development_of_a_Rights-Based_Counselling_Practice_and_Module_to_Reduce_Leprosy-Related_Stigma_and_Empower_People_Affected_by_Leprosy_in_Cirebon_District_Indonesia

Dharmawan, Y., Korfage, I.J., Abqari, U. et al. Measuring leprosy case detection delay and associated factors in Indonesia: a community-based study. BMC Infect Dis. 2023; 23:555 https://doi.org/10.1186/s12879-023-08552-x

Patil S, Mohanty KK, Joshi B, Bisht D; Rajkamal; Kumar A, Bansal AK. Towards Elimination of Stigma & Untouchability: A Case for Leprosy. Indian J Med Res. 2019; 149 (Suppl): S81-S87. doi: 10.4103/0971-5916.251663.

Giñan D, Esmérida A, Riberaux M, Cano J, Capdesuñer A, Revés L, Modificación de conocimientos sobre lepra en la atención primaria de salud. Medisan. 2011;15(6):745–53. Disponible en: https://www.semanticscholar.org/paper/Modificaci%C3%B3n-de-conocimientos-sobre-lepra-en-la-de-Gri%C3%B1an-Mart%C3%ADnez/f35161da80243fb04dd98489c66275c1da712407

Faus Dáder M, Amariles Muñoz P, Martínez-Martínez F. Atención farmacéutica conceptos, procesos y casos prácticos. Madrid. Ergon 2008.

Serrano-Coll HA, Cardona-Castro N. Neuropatía leprótica: una mirada integral de la afección periférica causada por Mycobacterium leprae. Revista Salud Uninorte. 2017;33(3):451–63. Disponible en: https://www.redalyc.org/pdf/817/81753881019.pdf

Han-Siong T, Maharjan J, Thapa R, et al. Diagnosis and impact of neuropathic pain in leprosy patients in Nepal after completion of multidrug therapy. PLoS Negl Trop Dis. 2018;12(7):1–15. https://doi.org/10.1371/journal.pntd.0006610

Gómez L, Rivera A, Vidal Y, Bilbao J, Kasang C, Parisi S, et al Factors associated with the delay of diagnosis of leprosy in north-eastern Colombia: a quantitative analysis. Trop Med Int Health. 2018; 23 (2):193–198. https://doi.org/10.1111/tmi.13023

Romero Montoya M, Beltrna J, Cardona N. Evaluation and Monitoring of Mycobacterium leprae Transmission in Household Contacts of Patients with Hansen’s Disease in Colombia. PLoS Negl Trop Dis. 2017; 11(1):e0005325. DOI:10.1371/journal.pntd.0005325

Santos VS, Oliveira LS, Castro FD, Gois-Santos VT, et al. Functional Activity Limitation and Quality of Life of Leprosy Cases in an Endemic Area in Northeastern Brazil. PLoS Negl Trop Dis. 2015; 9(7):e0003900. DOI:10.1371/journal.pntd.0003900

Cáceres-Durán M. Comportamiento epidemiológico de la lepra en varios países de América Latina, 2011-2020. Rev Panam Salud Publica. [Internet]. 2022;46:e 14 https://doi.org/10.26633/RPSP.2022.14

Published

2024-01-29

How to Cite

Aguilera, M. (2024). Educational pharmaceutical intervention in leprosy patients who have completed treatment. Pharmaceutical Care España, 26. https://doi.org/10.60103/phc.v26.e834

Issue

Section

Originales